发明名称 Adamantane derivatives
摘要 The invention provides adamantane derivatives of formula (I), a process for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy. In formula (I) D represents CH2 or CH2CH2, E represents C(O)NH or NHC(O) and R3 represents a group of formula (I).
申请公布号 US2009176853(A1) 申请公布日期 2009.07.09
申请号 US20080314156 申请日期 2008.12.04
申请人 发明人 ALCARAZ LILIAN;CAFFREY MOYA;FURBER MARK;LUKER TIMOTHY;MORTIMORE MICHAEL;PIMM AUSTEN;THORNE PHILIP;WILLIS PAUL
分类号 A61K31/4164;C07D233/64;A61K31/166;A61K31/167;A61K31/222;A61K31/417;A61P1/00;A61P1/04;A61P3/10;A61P7/00;A61P7/02;A61P9/08;A61P9/10;A61P9/14;A61P11/00;A61P11/06;A61P13/12;A61P17/00;A61P17/02;A61P17/06;A61P19/02;A61P19/10;A61P25/00;A61P25/28;A61P29/00;A61P35/00;A61P35/02;A61P35/04;A61P37/00;A61P37/06;A61P37/08;A61P43/00;C07C231/14;C07C233/01;C07C233/65;C07C233/88;C07C235/42;C07C235/46;C07C235/84;C07C237/30;C07C319/20;C07C323/25;C07D233/54;C07D233/58;C07D233/61;C07D521/00 主分类号 A61K31/4164
代理机构 代理人
主权项
地址